805 related articles for article (PubMed ID: 30496697)
1. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
Vangijzegem T; Stanicki D; Laurent S
Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
[TBL] [Abstract][Full Text] [Related]
2. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
3. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
[TBL] [Abstract][Full Text] [Related]
4. DNA-Iron Oxide Nanoparticles Conjugates: Functional Magnetic Nanoplatforms in Biomedical Applications.
Sosa-Acosta JR; Iriarte-Mesa C; Ortega GA; Díaz-García AM
Top Curr Chem (Cham); 2020 Jan; 378(1):13. PubMed ID: 31925680
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
Kumar P; Agnihotri S; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
[TBL] [Abstract][Full Text] [Related]
6. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide-doped niosomes as drug carriers for magnetically targeted drug delivery.
Juneja R; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):7-9. PubMed ID: 29593388
[TBL] [Abstract][Full Text] [Related]
8. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery.
Stanicki D; Vangijzegem T; Ternad I; Laurent S
Expert Opin Drug Deliv; 2022 Mar; 19(3):321-335. PubMed ID: 35202551
[TBL] [Abstract][Full Text] [Related]
9. Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery.
Kralj S; Potrc T; Kocbek P; Marchesan S; Makovec D
Curr Med Chem; 2017; 24(5):454-469. PubMed ID: 27528059
[TBL] [Abstract][Full Text] [Related]
10. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery.
Estelrich J; Escribano E; Queralt J; Busquets MA
Int J Mol Sci; 2015 Apr; 16(4):8070-101. PubMed ID: 25867479
[TBL] [Abstract][Full Text] [Related]
11. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
12. Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy.
Zakaria MB; Belik AA; Liu CH; Hsieh HY; Liao YT; Malgras V; Yamauchi Y; Wu KC
Chem Asian J; 2015 Jul; 10(7):1457-62. PubMed ID: 25944287
[TBL] [Abstract][Full Text] [Related]
13. Shape Anisotropic Iron Oxide-Based Magnetic Nanoparticles: Synthesis and Biomedical Applications.
Andrade RGD; Veloso SRS; Castanheira EMS
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32244817
[TBL] [Abstract][Full Text] [Related]
14. Magnetic iron oxide nanoparticles for tumor-targeted therapy.
Chen B; Wu W; Wang X
Curr Cancer Drug Targets; 2011 Feb; 11(2):184-9. PubMed ID: 21158723
[TBL] [Abstract][Full Text] [Related]
15. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
17. Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?
Bietenbeck M; Florian A; Faber C; Sechtem U; Yilmaz A
Int J Nanomedicine; 2016; 11():3191-203. PubMed ID: 27486321
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
[TBL] [Abstract][Full Text] [Related]
19. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
Ling D; Lee N; Hyeon T
Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
[TBL] [Abstract][Full Text] [Related]
20. Size-Controlled Iron Oxide Nanoplatforms with Lipidoid-Stabilized Shells for Efficient Magnetic Resonance Imaging-Trackable Lymph Node Targeting and High-Capacity Biomolecule Display.
Clauson RM; Chen M; Scheetz LM; Berg B; Chertok B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20281-20295. PubMed ID: 29883088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
